(19)
(11) EP 3 271 371 A1

(12)

(43) Date of publication:
24.01.2018 Bulletin 2018/04

(21) Application number: 16759215.3

(22) Date of filing: 02.03.2016
(51) International Patent Classification (IPC): 
C07H 19/10(2006.01)
A61P 31/14(2006.01)
 A61K 31/7072(2006.01)
(86) International application number:
PCT/SE2016/050166
(87) International publication number:
WO 2016/140615 (09.09.2016 Gazette 2016/36)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 02.03.2015 SE 1550242
04.03.2015 SE 1550256
04.03.2015 SE 1550257
04.03.2015 SE 1550258
04.03.2015 SE 1550259
04.03.2015 SE 1550260
04.03.2015 SE 1550261
04.03.2015 SE 1550265

(71) Applicant: MEDIVIR AB
141 22 Huddinge (SE)

(72) Inventors:
  • KALAYANOV, Gennadiy
    141 22 Huddinge (SE)
  • PINHO, Pedro
    141 22 Huddinge (SE)
  • TARGETT-ADAMS, Paul
    141 22 Huddinge (SE)
  • TORSSELL, Staffan
    141 22 Huddinge (SE)

   


(54) NUCLEOTIDE DERIVATIVES WHICH ARE HCV INHIBITORS FOR USE IN THE TREATMENT OF HEPATITIS C